Stem Cell Patent Case Will Be Early Test Of Myriad's Reach
A suit seeking to invalidate a patent on human embryonic stem cells could provide some early indication as to whether the U.S. Supreme Court's ruling that isolated DNA cannot be patented...To view the full article, register now.
Already a subscriber? Click here to view full article